Jiangang Zou

Cardiac Electrophysiology | Director of Internal Medicine | Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University

[Jiangang Zou @jgzoumd]

Pleased to introduce our LBBP-RESYNC trial online today in #JACC First head to head comparison of LBBP vs BiVP in CRT for nonischemic patients. Significantly greater increase in LVEF with LBBP at 6 month! @MdHuang @KennethEllenbo1 @DrMGold1 @JasperZouMD https://t.co/5rskzNpkr2

[Jiangang Zou @jgzoumd]

@KennethEllenbo1

[Jiangang Zou @jgzoumd]

Our study showing early LBBP resynchronization at index diagnosis for HFmfEF with LBBB significantly improves LVEF and clinical outcomes at 6 months compared to GDMT alone! Restoring LVEF back to normal and reduces HF hospitalization @JasperZouMD @hrs_journal

[Peng-Sheng Chen, MD @DrPengShengChen]

"Early Left Bundle Branch Pacing in Heart Failure with Mildly-Reduced Ejection Fraction and Left Bundle Branch Block" by Jiangang Zou et al. has been accepted for publication by Heart Rhythm.

[Jiangang Zou @jgzoumd]

Great to be finally back at #HRS2023 after three years, seeing old friends, meeting new ones and constant learning about the field. So privileged to be part of this fascinating field.

[Mihail G. Chelu, MD, PhD @MihailChelu]

Great China-US session hosted by legend @MdHuang at the 6th Symposium of His-Purkinje Conduction System Pacing (HPCSP). Good to meet colleagues and exchange ideas: @jgzoumd Keping Chen @cha_yongmei @gauravaupadhyay @psharmadoc @dontdisGD

[Jiangang Zou @jgzoumd]

@Nishaki1 @ikutinsky1 @SimonDixonMBChB @IvanHansonMD @AkhilGulati @PamelaMasonEP @drkuldeep_shah @EladAnter @shivkumarmd @dhaines901 @DrCJBradley @DrBradleyKnight Dave is my mentor in UVA in 2002-2003. Terrific water skiing.

[Jiangang Zou @jgzoumd]

LBBP is a novel and revolutionary physiological pacing modality, which is expected to be the preferred strategy of resynchronization therapy for patients with heart failure and left bundle branch block.

[JACC Journals @JACCJournals]

Left bundle branch pacing: A viable option for CRT in #HeartFailure patients? https://t.co/xRNCVKaZMe

#JACC #LVEF #CardioTwitter @JGZOUMD

[Jiangang Zou @jgzoumd]

Thanks to the hard work of all collaborators! Looking forward to bigger outcome-based RCTs to come! Thoughtful editorial by @Hisdoc1 shining light on what’s needed ahead. @MihailChelu @Marek_Jastrz_EP @DrRoderickTung @EP_mom1 @ZacharyWhinnett @psharmadoc @gauravaupadhyay

[Jiangang Zou @jgzoumd]

Pleased to introduce our LBBP-RESYNC trial online today in #JACC First head to head comparison of LBBP vs BiVP in CRT for nonischemic patients. Significantly greater increase in LVEF with LBBP at 6 month! @MdHuang @KennethEllenbo1 @DrMGold1 @JasperZouMD https://t.co/5rskzNpkr2

[Fengwei Jasper Zou @JasperZouMD]

Privileged to present the LBBP-RESYNC pilot trial at the late breaking clinical trial session at #HRS2022 on behalf of Dr. Jiangang Zou. LBBP-RESYNC is the first RCT showing LBBP’s superior improvement of LVEF compared to BiV-CRT. @HRSonline